Tickers

1. Composite Trajectory Verdict

Given GPC's acquisition-intensive distribution model and significant debt obligations, the cash flow statement carries the most weight for assessing financial trajectory, as it reveals the capacity to fund acquisitions, service debt, and sustain dividends without relying on external financing.

Composite Trajectory: Mixed

Revenue growth is consistent across annual and quarterly periods (3.5% FY2025, 6.4% 6M2026), and gross margin has expanded steadily (35.9% FY2023 → 36.3% FY2024 → 36.8% FY2025; 37.4% 6M2025 → 37.6% 6M2026). However, SG&A has grown faster than revenue in every comparable period (7.6% vs 3.5% FY2025; 8.4% vs 6.4% 6M2026), compressing operating leverage. GAAP net income collapsed 92.7% in FY2025 due to $996M in discrete charges (pension settlement, First Brands, asbestos), while adjusted net income fell 10%. Quarterly GAAP net income also declined (–10.7% Q2, –7.4% 6M) despite revenue growth, though adjusted net income rose modestly (+1.5% Q2, +1.1% 6M). Operating cash flow dropped 28.8% in FY2025 but surged 174% in 6M2026 (aided by a $250M A/R facility benefit). Debt has risen each period ($4.3B FY2024 → $4.8B FY2025 → ~$5.0B Q2 2026), outpacing EBITDA growth. The improving dimensions are revenue, gross margin, and Industrial segment profitability; the deteriorating dimensions are SG&A leverage, GAAP earnings, annual operating cash flow, and balance sheet leverage.

2. Red Flags

• GAAP net income collapse despite revenue growth: FY2025 net income $65.9M vs $904.1M FY2024 (–92.7%) driven by $742M pension settlement, $151M First Brands credit loss, $103M asbestos remeasurement (10-K FY2025, Consolidated Statements of Income).
• SG&A consistently outpacing revenue: FY2025 SG&A +7.6% vs sales +3.5%; 6M2026 SG&A +8.4% vs sales +6.4% (10-K FY2025, MD&A; 10-Q Q2 2026, MD&A).
• Annual operating cash flow declining sharply: FY2025 $890.8M vs FY2024 $1,251.3M (–28.8%) vs FY2023 $1,435.6M (10-K FY2025, Consolidated Statements of Cash Flows).
• Rising debt and interest expense: Total debt $4.3B FY2024 → $4.8B FY2025 → ~$5.0B Q2 2026; net interest expense $96.8M FY2024 → $163.5M FY2025 → $89.8M 6M2026 (10-K FY2025, Note 6; 10-Q Q2 2026, MD&A).
• "Non-recurring" charges recurring across periods: Restructuring costs $213.5M FY2024, $254.0M FY2025, $128.9M 6M2026; asbestos liability increased $107M in FY2025 (10-K FY2025, MD&A; 10-Q Q2 2026, MD&A).
• Widening GAAP vs. adjusted earnings gap: FY2025 GAAP EPS $0.47 vs adjusted $7.37; 6M2026 GAAP EPS $3.01 vs adjusted $3.92 (10-K FY2025, Non-GAAP reconciliation; 10-Q Q2 2026, Non-GAAP reconciliation).
• Working capital cash drag: FY2025 inventory increased $557.6M (cash outflow $208.2M) while payables decreased $132.7M (10-K FY2025, Consolidated Statements of Cash Flows).
• Near-term debt maturities: $1.3B due within one year at FY2025; $1.3B due in 2026 per maturity schedule (10-K FY2025, Note 6).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue has grown in each annual period (FY2023 $23.09B → FY2024 $23.49B → FY2025 $24.30B) and in the most recent quarterly periods (6M2025 $12.03B → 6M2026 $12.80B, +6.4%). Gross margin has expanded each year (35.9% → 36.3% → 36.8%) and in 6M2026 (37.6% vs 37.4%). However, SG&A as a percentage of sales has risen steadily (26.7% FY2023 → 28.3% FY2024 → 29.4% FY2025; 28.9% 6M2025 → 29.5% 6M2026). GAAP operating income declined from $1,747M FY2023 to $1,229M FY2024 to $961M FY2025. GAAP net income fell from $1,317M FY2023 to $904M FY2024 to $66M FY2025, though the FY2025 decline was driven by $996M in discrete charges. Adjusted net income declined 10% in FY2025 ($1,026M vs $1,140M) but rose 1.1% in 6M2026 ($541M vs $535M). Segment trends diverge: Industrial EBITDA margin improved (12.8% FY2023 → 12.6% FY2024 → 12.9% FY2025; 13.3% 6M2026), while North America Automotive margin fell (8.7% → 7.8% → 7.1%; 7.4% 6M2026) and International Automotive margin fell (10.5% → 10.2% → 9.3%; 9.3% 6M2026).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow has declined for two consecutive years: FY2023 $1,435.6M → FY2024 $1,251.3M (–12.8%) → FY2025 $890.8M (–28.8%). The FY2025 decline was driven by lower net income, higher interest payments ($191.3M vs $125.0M), and working capital changes including a $208.2M inventory build and $132.7M payable reduction (10-K FY2025, Consolidated Statements of Cash Flows). Conversely, 6M2026 operating cash flow jumped to $464.1M from $169.1M in 6M2025 (+174.4%), with the MD&A citing a $250M benefit from the A/R Sales Agreement and improved working capital (10-Q Q2 2026, MD&A). Capital expenditures have been relatively stable: FY2023 $512.7M → FY2024 $567.3M → FY2025 $469.8M; 6M2026 $205M. Free cash flow (operating – capex) was $923M FY2023, $684M FY2024, $421M FY2025, and $259M 6M2026. Acquisitions spending slowed: FY2024 $1,080M → FY2025 $318M → 6M2026 $38M. Dividends paid have risen each period: FY2023 $526.7M → FY2024 $554.9M → FY2025 $563.8M → 6M2026 $288M (annualized ~$576M).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total debt has increased each period: $4.28B FY2024 → $4.80B FY2025 → ~$5.0B June 2026 (10-K FY2025, Note 6; 10-Q Q2 2026, MD&A). Cash has remained flat (~$477M FY2024 → $477M FY2025 → $559M June 2026). Net debt (debt less cash) has risen correspondingly. The current ratio slipped from 1.16x (FY2024: $9,853M/$8,525M) to 1.08x (FY2025: $10,565M/$9,788M) to 1.16x (June 2026: $11,066M/$9,548M). Goodwill and intangibles grew from $4.70B FY2024 to $5.04B FY2025 to $4.96B June 2026, representing 24-25% of total assets. Accumulated other comprehensive loss improved from –$1,262M FY2024 to –$512M FY2025 (largely due to pension settlement) but widened to –$549M June 2026. Total equity grew modestly ($4,352M FY2024 → $4,440M FY2025 → $4,544M June 2026), but retained earnings fell from $5,264M to $4,569M to $4,692M due to net income declines and dividend payments exceeding earnings. Debt-to-adjusted-EBITDA rose from ~2.1x (FY2024: $4.28B/$1,997M) to ~2.4x (FY2025: $4.80B/$2,006M).

6. Data Gaps

• Quarterly income statement and cash flow data for Q1 2026, Q3 2025, Q2 2025, Q1 2025 (only 6M and Q2 2026 vs 2025 are provided in the 10-Q MD&A; full quarterly statements not included)
• Quarterly balance sheets for March 31, 2026 and September 30, 2025 (only June 30, 2026 and December 31, 2025 provided)
• Segment-level quarterly EBITDA for periods prior to Q2 2026 (only annual segment EBITDA for 2023-2025 and Q2/6M 2026 vs 2025 provided)
• Quarterly free cash flow for periods prior to 6M2026 (only annual and 6M2026 available)
• Detailed working capital breakdown for quarterly periods (only annual cash flow statement shows inventory, receivables, payables changes)
• Debt covenant compliance metrics (debt/EBITDA ratio) for quarterly periods (only annual covenant compliance stated)